scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...873443L |
P5530 | Altmetric DOI | 10.1371/JOURNAL.PONE.0073443 |
P6409 | CORE ID | 90152451 |
P6179 | Dimensions Publication ID | 1044418113 |
P356 | DOI | 10.1371/JOURNAL.PONE.0073443 |
P953 | full work available at URL | http://eprints.whiterose.ac.uk/86520 |
P932 | PMC publication ID | 3774691 |
P698 | PubMed publication ID | 24066048 |
P5875 | ResearchGate publication ID | 257072718 |
P50 | author | Massimo Negrini | Q28324645 |
Manuela Ferracin | Q28324648 | ||
Michael McDermott | Q40340920 | ||
Luca Cantarini | Q30505846 | ||
Orso Maria Lucherini | Q31159907 | ||
Giampaolo Merlini | Q37839101 | ||
Laura Obici | Q56426698 | ||
Valerio Fulci | Q56426709 | ||
Cosima Tatiana Baldari | Q59660191 | ||
Flora Magnotti | Q63373410 | ||
Mauro Galeazzi | Q73480279 | ||
Rolando Cimaz | Q88307472 | ||
Isabella Muscari | Q117235767 | ||
Laura J Dickie | Q117235769 | ||
P2860 | cites work | MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis | Q21091178 |
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes | Q24329184 | ||
The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers | Q24535763 | ||
The functions of animal microRNAs | Q27860621 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome | Q28277847 | ||
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study | Q40297017 | ||
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. | Q40310083 | ||
Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. | Q40357954 | ||
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series | Q40358488 | ||
TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept. | Q40421907 | ||
Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to eta | Q40430037 | ||
Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. | Q40493938 | ||
Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): c | Q40565049 | ||
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. | Q42844617 | ||
Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications | Q46969655 | ||
Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity | Q47037320 | ||
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma | Q29614238 | ||
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. | Q33942272 | ||
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review | Q34285481 | ||
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder | Q34917526 | ||
MicroRNAs in systemic rheumatic diseases | Q35617586 | ||
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene | Q35637824 | ||
Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms | Q36205231 | ||
MicroRNAs: novel regulators of immunity. | Q37387819 | ||
Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study | Q37438706 | ||
Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 | ||
MicroRNAs in inflammation and immune responses | Q37969887 | ||
Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids. | Q38031583 | ||
Amyloidosis in autoinflammatory syndromes | Q38033402 | ||
Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives | Q38033875 | ||
MicroRNAs in the p53 network: micromanagement of tumour suppression | Q38035144 | ||
Developing microRNA therapeutics: approaching the unique complexities. | Q38036732 | ||
The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome | Q38975015 | ||
Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response | Q39373924 | ||
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations | Q39790268 | ||
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. | Q51570125 | ||
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. | Q54806502 | ||
Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis | Q58030171 | ||
Successful Treatment of Tumor Necrosis Factor Receptor–Associated Periodic Syndrome With Canakinumab | Q58326215 | ||
Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS) | Q80174645 | ||
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins | Q83586463 | ||
Secreted monocytic miR-150 enhances targeted endothelial cell migration | Q84525686 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
TNF | Q18032037 | ||
P304 | page(s) | e73443 | |
P577 | publication date | 2013-09-16 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). | |
P478 | volume | 8 |
Q35219001 | An expanding role for interleukin-1 blockade from gout to cancer |
Q97426341 | Assessment of Circulating Microribonucleic Acids in Patients With Familial Mediterranean Fever |
Q35824254 | Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC. |
Q26751292 | Familial Mediterranean fever: current perspectives |
Q89819649 | Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases |
Q50152542 | Inositol-Requiring Enzyme 1-Mediated Downregulation of MicroRNA (miR)-146a and miR-155 in Primary Dermal Fibroblasts across Three TNFRSF1A Mutations Results in Hyperresponsiveness to Lipopolysaccharide |
Q35133812 | Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives |
Q90220301 | Interleukin-1β Induces Intracellular Serum Amyloid A1 Expression in Human Coronary Artery Endothelial Cells and Promotes its Intercellular Exchange |
Q38220758 | Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome |
Q30665824 | MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples. |
Q40070170 | Microarray analysis of circulating microRNAs in familial Mediterranean fever. |
Q40959067 | Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes |
Q92993003 | NPCMF: Nearest Profile-based Collaborative Matrix Factorization method for predicting miRNA-disease associations |
Q52663863 | Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis. |
Q56974566 | Serum amyloid-A in Behçet’s disease |
Q38843398 | Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens |
Q38222307 | The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy |
Q37636664 | Treating inflammation by blocking interleukin-1 in humans |
Q41929105 | Tumor necrosis factor-associated periodic syndrome in adults. |
Search more.